Investors

• Shareholders' room

 

To pursue its development, Affichem decided to open its capital to any natural person in 2011.
Thus, each of us can become an actor of the breakthroughs of the Medical Research and help ensure a better health for the future generations.

To do this, simply become a shareholder of Affichem by buying shares. Such investments are partly tax deductible if you are taxable in France (up to 50% of the amount within the limit of € 45,000 per year per person for ISF tax, and up to 22% of the amount within the limit of € 20,000 per year per person, or € 40,000 per year for a couple for IRPP tax).

Download : Subscription form (PDF)

For additional information, a detailed prospectus on the proposed business development at 5 years and the ethics of this call for public savings is available on the website of the association « Love Money pour l’Emploi » : www.love-money.org

A newspaper article on the “Love Money” concept is available here.

Up until now, Affichem was financially supported by the founders and public funds.
 
The melanoma project was partly financed by the French ministry of research (GenHomme project) and the deafness is supported by the European Community through the project EuroHear - FP6 (Research Framework Programme) coordinated by Pr Christine Petit (Pasteur Institute, Paris, France).

Today, Affichem is seeking partners to develop its R&D programs (AML, breast cancer, melanoma and deafness projects) as well as new indications in the cancer and the neurodegenerative diseases fields.

In parallel, a fund-raising program is planned in 2011.